tirzepatide attenuates mammary tumor progression in diet induced obese mice retention iWAT with mesoporous polydopamine encapsulation enhances weight loss through leptin receptor signaling E0771 tumor growth can be

The research analyzed the medical records of 120 postmenopausal women over a median of 18 months , including 40 women who received hormone therapy alongside tirzepatide and 80 who used tirzepatide alone

Unlike pharmaceutical GLP-1 agonists, which can cause gastrointestinal side effects such as nausea, vomiting, and diarrhoea, dietary approaches rarely produce significant adverse effects when implemented gradually

I 2 = 96%] or for patients without T2DM [MD = 1.10, 95% CI (6.49, 8.69)

The drugmaker, which has signed semi-exclusive licensing partnerships with Lupin and Torrent Pharma, has regulatory approval to make and market semaglutide for both type 2 diabetes and weight management

and (3) studies lacking adequate control groups or failing to report statistical significance

Funnel plots for AF, AFL, VAs, and SCD displayed symmetry (Additional file 1: Fig